表紙
市場調查報告書
商品編碼
1028939

乳癌的單株抗體的全球市場:COVID-19的成長及變化預測 (∼2030年)

Breast Cancer Monoclonal Antibodies Global Market Report 2021: COVID-19 Growth And Change To 2030

出版日期: 按訂單生產 | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

本報告提供全球乳癌的單株抗體的市場調查,彙整市場定義和概要,新型冠狀病毒感染疾病 (COVID-19) 以及其他的市場影響因素分析,市場規模的轉變·預測,產品·終端用戶·治療方法·地區/主要國家等各種區分的明細,競爭環境,主要企業的簡介,未來展望等資料。

目錄

第1章 摘要整理

第2章 市場特徵

第3章 市場趨勢·市場策略

第4章 COVID-19的影響

第5章 市場規模·成長預測

  • 市場規模的轉變·預測
  • 市場成長的促進因素
  • 市場阻礙成長要素

第6章 市場分析·預測:各種區分

  • 各產品
    • 裸單株抗體
    • 共軛單株抗體
  • 各終端用戶
    • 醫院
    • 零售藥局
  • 不同治療
    • 化療
    • 手術·放射線治療
    • 標靶治療
    • 生物學的療法
    • 荷爾蒙療法

第7章 市場分析·預測:各地各國

第8章 亞太地區市場分析·預測

  • 市場概要
  • 地區資訊·COVID-19的影響·市場資訊·背景資訊·政府措施·法律規章·機關&協會·租稅·投資·主要企業
  • 市場分析·預測:各產品
  • 市場分析·預測:各終端用戶

第9章 中國市場分析·預測

第10章 印度市場分析·預測

第11章 日本市場分析·預測

第12章 澳洲市場分析·預測

第13章 印尼市場分析·預測

第14章 韓國市場分析·預測

第15章 西歐市場分析·預測

第16章 英國市場分析·預測

第17章 德國市場分析·預測

第18章 法國市場分析·預測

第19章 東歐市場分析·預測

第20章 俄羅斯市場分析·預測

第21章 北美市場分析·預測

第22章 美國市場分析·預測

第23章 南美市場分析·預測

第24章 巴西市場分析·預測

第25章 中東市場分析·預測

第26章 非洲市場分析·預測

第27章 競爭情形·企業簡介

  • 競爭情形
  • 企業簡介
    • Amgen
    • Mylan
    • Merck
    • Novartis
    • GlaxoSmithKline

第28章 開發平台分析

第28章 主要M&A

第29章 未來展望·潛在性分析

第30章 附錄

目錄
Product Code: h964

Breast Cancer Monoclonal Antibodies Global Market Report 2021: COVID-19 Growth And Change to 2030 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global breast cancer monoclonal antibodies (mabs) market.

This report focuses on breast cancer monoclonal antibodies (mabs) market which is experiencing strong growth. The report gives a guide to the breast cancer monoclonal antibodies (mabs) market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the breast cancer monoclonal antibodies (mabs)? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Breast Cancer Monoclonal Antibodies (mAbs) market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider breast cancer monoclonal antibodies (mabs) market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The breast cancer monoclonal antibodies (mabs) market section of the report gives context. It compares the breast cancer monoclonal antibodies (mabs) market with other segments of the breast cancer monoclonal antibodies (mabs) market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, breast cancer monoclonal antibodies (mabs) indicators comparison.

Scope

Markets Covered: 1) By Product: Naked Mabs; Conjugated Mabs

2) By End-User: Hospitals; Retail Pharmacies

3) By Treatment: Chemotherapy; Surgery & Radiation Therapy; Targeted Therapy; Biologic Therapy; Hormone Therapy

Companies Mentioned: Amgen; Mylan; Merck; Novartis; GlaxoSmithKline

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Breast Cancer Monoclonal Antibodies Market Characteristics

3. Breast Cancer Monoclonal Antibodies Market Trends And Strategies

4. Impact Of COVID-19 On Breast Cancer Monoclonal Antibodies

5. Breast Cancer Monoclonal Antibodies Market Size And Growth

  • 5.1. Global Breast Cancer Monoclonal Antibodies Historic Market, 2015-2020, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global Breast Cancer Monoclonal Antibodies Forecast Market, 2020-2025F, 2030F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. Breast Cancer Monoclonal Antibodies Market Segmentation

  • 6.1. Global Breast Cancer Monoclonal Antibodies Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Naked Mabs
  • Conjugated Mabs
  • 6.2. Global Breast Cancer Monoclonal Antibodies Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Hospitals
  • Retail Pharmacies
  • 6.3. Global Breast Cancer Monoclonal Antibodies Market, Segmentation By Treatment, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Chemotherapy
  • Surgery & Radiation Therapy
  • Targeted Therapy
  • Biologic Therapy
  • Hormone Therapy

7. Breast Cancer Monoclonal Antibodies Market Regional And Country Analysis

  • 7.1. Global Breast Cancer Monoclonal Antibodies Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 7.2. Global Breast Cancer Monoclonal Antibodies Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

8. Asia-Pacific Breast Cancer Monoclonal Antibodies Market

  • 8.1. Asia-Pacific Breast Cancer Monoclonal Antibodies Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Breast Cancer Monoclonal Antibodies Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 8.3. Asia-Pacific Breast Cancer Monoclonal Antibodies Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

9. China Breast Cancer Monoclonal Antibodies Market

  • 9.1. China Breast Cancer Monoclonal Antibodies Market Overview
  • 9.2. China Breast Cancer Monoclonal Antibodies Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
  • 9.3. China Breast Cancer Monoclonal Antibodies Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

10. India Breast Cancer Monoclonal Antibodies Market

  • 10.1. India Breast Cancer Monoclonal Antibodies Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 10.2. India Breast Cancer Monoclonal Antibodies Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

11. Japan Breast Cancer Monoclonal Antibodies Market

  • 11.1. Japan Breast Cancer Monoclonal Antibodies Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 11.2. Japan Breast Cancer Monoclonal Antibodies Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

12. Australia Breast Cancer Monoclonal Antibodies Market

  • 12.1. Australia Breast Cancer Monoclonal Antibodies Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 12.2. Australia Breast Cancer Monoclonal Antibodies Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

13. Indonesia Breast Cancer Monoclonal Antibodies Market

  • 13.1. Indonesia Breast Cancer Monoclonal Antibodies Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 13.2. Indonesia Breast Cancer Monoclonal Antibodies Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

14. South Korea Breast Cancer Monoclonal Antibodies Market

  • 14.1. South Korea Breast Cancer Monoclonal Antibodies Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 14.2. South Korea Breast Cancer Monoclonal Antibodies Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

15. Western Europe Breast Cancer Monoclonal Antibodies Market

  • 15.1. Western Europe Breast Cancer Monoclonal Antibodies Market Overview
  • 15.2. Western Europe Breast Cancer Monoclonal Antibodies Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 15.3. Western Europe Breast Cancer Monoclonal Antibodies Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

16. UK Breast Cancer Monoclonal Antibodies Market

  • 16.1. UK Breast Cancer Monoclonal Antibodies Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 16.2. UK Breast Cancer Monoclonal Antibodies Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

17. Germany Breast Cancer Monoclonal Antibodies Market

  • 17.1. Germany Breast Cancer Monoclonal Antibodies Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 17.2. Germany Breast Cancer Monoclonal Antibodies Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

18. France Breast Cancer Monoclonal Antibodies Market

  • 18.4. France Breast Cancer Monoclonal Antibodies Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 18.5. France Breast Cancer Monoclonal Antibodies Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

19. Eastern Europe Breast Cancer Monoclonal Antibodies Market

  • 19.1. Eastern Europe Breast Cancer Monoclonal Antibodies Market Overview
  • 19.2. Eastern Europe Breast Cancer Monoclonal Antibodies Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 19.3. Eastern Europe Breast Cancer Monoclonal Antibodies Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

20. Russia Breast Cancer Monoclonal Antibodies Market

  • 20.1. Russia Breast Cancer Monoclonal Antibodies Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 20.2. Russia Breast Cancer Monoclonal Antibodies Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

21. North America Breast Cancer Monoclonal Antibodies Market

  • 21.1. North America Breast Cancer Monoclonal Antibodies Market Overview
  • 21.2. North America Breast Cancer Monoclonal Antibodies Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 21.3. North America Breast Cancer Monoclonal Antibodies Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

22. USA Breast Cancer Monoclonal Antibodies Market

  • 22.1. USA Breast Cancer Monoclonal Antibodies Market Overview
  • 22.2. USA Breast Cancer Monoclonal Antibodies Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 22.3. USA Breast Cancer Monoclonal Antibodies Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

23. South America Breast Cancer Monoclonal Antibodies Market

  • 23.1. South America Breast Cancer Monoclonal Antibodies Market Overview
  • 23.2. South America Breast Cancer Monoclonal Antibodies Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 23.3. South America Breast Cancer Monoclonal Antibodies Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

24. Brazil Breast Cancer Monoclonal Antibodies Market

  • 24.1. Brazil Breast Cancer Monoclonal Antibodies Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 24.2. Brazil Breast Cancer Monoclonal Antibodies Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

25. Middle East Breast Cancer Monoclonal Antibodies Market

  • 25.1. Middle East Breast Cancer Monoclonal Antibodies Market Overview
  • 25.2. Middle East Breast Cancer Monoclonal Antibodies Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 25.3. Middle East Breast Cancer Monoclonal Antibodies Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

26. Africa Breast Cancer Monoclonal Antibodies Market

  • 26.1. Africa Breast Cancer Monoclonal Antibodies Market Overview
  • 26.2. Africa Breast Cancer Monoclonal Antibodies Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 26.3. Africa Breast Cancer Monoclonal Antibodies Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

27. Breast Cancer Monoclonal Antibodies Market Competitive Landscape And Company Profiles

  • 27.1. Breast Cancer Monoclonal Antibodies Market Competitive Landscape
  • 27.2. Breast Cancer Monoclonal Antibodies Market Company Profiles
    • 27.2.1. Amgen
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. Mylan
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. Merck
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. Novartis
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. GlaxoSmithKline
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Breast Cancer Monoclonal Antibodies Pipeline Analysis

29. Key Mergers And Acquisitions In The Breast Cancer Monoclonal Antibodies Market

30. Breast Cancer Monoclonal Antibodies Market Future Outlook and Potential Analysis

31. Appendix

  • 31.1. Abbreviations
  • 31.2. Currencies
  • 31.3. Research Inquiries
  • 31.4. The Business Research Company
  • 31.5. Copyright And Disclaimer